tissues was demonstrated (Honda et al., 1991; Ye et al., 1991; Bito et al., 1994; Ishii et al., 1996) . Notably, Although platelet-activating factor (PAF) has been leukocytes accumulate enormous amounts of PAFR shown to exert pleiotropic effects on isolated cells or mRNA.
tissues, controversy still exists as to whether it plays
We found two species of human PAFR transcripts, significant pathophysiological roles in vivo. To answer transcript 1 and 2, with identical open reading frames this question, we established transgenic mice over- (Mutoh et al., 1993 (Mutoh et al., , 1994a (Mutoh et al., ,b, 1996 . These are driven by expressing a guinea-pig PAF receptor (PAFR). The individual promoters and are expressed tissue specifically; transgenic mice showed a bronchial hyperreactivity to transcript 1 is ubiquitous and most abundant in leukocytes, methacholine and an increased mortality when exposed while transcript 2 is located in heart, lung, spleen and to bacterial endotoxin. An aberrant melanogenesis kidney but not in leukocytes or brain. Such dual promoter and proliferative abnormalities in the skin were also systems facilitate the high expression of PAFR mRNA in observed in the transgenic mice, some of which sponleukocytes, while maintaining the expression at a lower taneously bore melanocytic tumors in the dermis after level in other cells and tissues, under physiological condiaging. Thus, PAFR transgenic mice proved to be a tions. Augmentation of the message level in other tissues useful model for studying the basic pathophysiology of is closely related to the pathogenesis of various disorders; bronchial asthma and endotoxin-induced death, and PAFR mRNA significantly increased in the lung tissue of screening of therapeutics for these disorders. Furtherasthmatic patients (Shirasaki et al., 1994) . This report is more, our findings provide new insights regarding the of particular interest since deficiency of plasma PAF role of PAF in the morphogenesis of dermal tissues as acetylhydrolase is associated with severe respiratory sympwell as the mitogenic activity of PAF and PAFR in vivo. et al., 1991) . Northern blot analysis demonstrated the Platelet-activating factor (PAF, 1-O-alkyl-2-acetyl-snexpression of the transgene in heart, skeletal muscle, eye, glycero-3-phosphocholine) is a phospholipid mediator with skin, trachea and aorta. PAFR transgenic mice exhibited pleiotropic and potent biological effects on a variety of bronchial hyperreactivity to PAF or methacholine, and an cells and tissues (Hanahan, 1986; Prescott et al., 1990;  increased lethality to bacterial endotoxin (lipopolysaccha- Chao and Olson, 1993; Izumi and Shimizu, 1995) . Activride, LPS). Various unexpected phenotypes included an ation of peripheral leukocytes by PAF is thought to be abnormal breeding pattern, and epidermal and dermal a key step in the pathogenesis of many allergic and hyperthickening with dermal melanosis. In some aged inflammatory disorders. Several lines of evidence have transgenic mice with a pronounced histopathology in also suggested that PAF has various pathophysiological the skin, melanocytic tumors arose spontaneously in the effects on cardiovascular, respiratory and gastrointestinal dermis. Thus, these transgenic mice are a pertinent model systems (Stewart and Delbridge, 1993) . Moreover, PAF is of bronchial asthma and endotoxin-induced lethality. Furconsidered to play physiological roles in the reproductive thermore, our findings provide important insights into the (O'Neill, 1992; Pike et al., 1992; Toyoshima et al., 1995) novel roles of PAF in cell proliferation and subsequent tumor formation in the skin. and central nervous systems (Bazan, 1990; Kato et al., Results medium levels in eye, skin, trachea and aorta, and barely detectable levels in neutrophils, brain, lung, liver, spleen, Establishment of PAFR transgenic mice kidney, small intestine, uterus and testis ( Figure 2B ). The guinea-pig PAFR cDNA was placed under the regulaTransgenic mRNAs were detected above 18S rRNA. In tion of the chicken β-actin promoter and the CMV the control mice, hybridization signals were not observed immediate early enhancer (Figure 1) . A 4.1 kb BamHI-(data not shown). The membrane was re-hybridized with BamHI fragment of the transgene construct ( Figure 1 ) was a murine PAFR probe. Although we have reported the microinjected into the pronuclei of fertilized eggs. Of 87 ubiquitous expression of murine PAFR mRNA (Ishii et al., offspring, four founders (F 0 mice) were identified by PCR 1996), the murine PAFR mRNA was detected below 28S screening; at 7-8 weeks old, two of them spontaneously rRNA only in neutrophils under these conditions because developed necrosis in the hind legs or in the eyes. Though of the low amount of total RNA (3 μg) loaded on the all founders were fertile, only one male founder (F 0 55) membrane ( Figure 2B ). The transgene expression pattern transmitted the transgene through the germline. Subsequent of 55-L transgenic mice was similar to that of 55-H (data analysis of tail DNA of F 0 55 and its offspring transgenic not shown). Unless stated otherwise, 55-H transgenic mice mice by Southern blotting revealed that this line segregated (F 2 -F 4 ) were used in the following studies, with their into two sublines based on the copy number of integrated wild-type littermates as control. transgenes. This is probably due to two transgene integraTo verify transgene overexpression in the heart, ligand tion sites in the chromosomes of F 0 55 mouse. These two binding assays were done on cardiac membranes by using sublines contained~50 and 100 copies of the transgene a 3 H-labeled PAF antagonist, WEB 2086 (Casals-Stenzel, (data not shown), and were designated 55-L and 55-H, 1987) . The membranes were prepared by homogenizing respectively. Northern blot analysis of RNAs extracted whole hearts from the transgenic and control mice. While from heart and skeletal muscle of F 2 or F 3 mice confirmed membranes of control mice (n ϭ 5) showed no binding the establishment of the two sublines ( Figure 2A ). When activities under our assay conditions, those of the transthe expression of the transgenic PAFR mRNA was comgenic mice showed high PAFR densities (3.24 Ϯ pared in the two groups, 55-H showed 5-to 10-fold higher 0.73 pmol/mg protein, mean Ϯ SEM, n ϭ 4). expression than 55-L.
Introduction
Northern blot analysis, using a guinea-pig-specific Anatomical and biochemical examinations PAFR probe, of tissue RNAs from 55-H transgenic mice
No gross morphological abnormalities were detected in showed a restricted pattern of transgene expression: high three males each of the transgenic mice and their littermate levels of expression were seen in heart and skeletal muscle, control mice (23 or 35 weeks old) and were found to be normal except for the skin of the ear and tail of the transgenic mice (see below). Light microscopic evaluation of heart, skeletal muscle, thymus, spleen, bone marrow and mesenteric lymph nodes showed no abnormalities. Measurement of body weight of 14-to 17-week-old mice revealed that the transgenic mice were~20% lighter than their control littermates of either gender (data not shown).
The following parameters were all normal: erythrocyte, platelet and leukocyte counts, proportion and morphology creatinine (data not shown). Reduced fertility and gender bias of offspring the transgenic ratio among females (1:3.0) was significantly lower than the transgenic ratio among males (1:1.8) The transgenic heterozygous females produced rare transgenic progenies: out of 20 pups, only two were transgenic.
( Table I ). Each generation of transgenic mice showed similar results. Post-natal deaths were rarely observed. Thereafter, progeny were generated by mating heterozygous F 1 to F 3 males to wild-type (BDF 1 ) females.
The fertility of 55-L transgenic male was normal with regard to the sex (data not shown) and the transgenic ratio However, the proportion of transgenic progeny to control progeny, 1:2.3 (Table I) , was significantly lower than that of the progeny (Table II) . The mean litter size was 8.2 Ϯ 0.9 (mean Ϯ SEM, n ϭ 10). This value is significantly expected from Mendelian distribution (1:1). In addition, larger (P Ͻ 0.005; two-tailed, unpaired t test) than that observed with the 55-H males that produced progeny mice. Figure mouse. While the control mouse did not respond to PAF, the transgenic mouse showed a marked bronchoconstric- genic mice ( Figure 3B ), whereas these changes were not airway response to methacholine was reduced by the PAF Fisher's exact test), as compared with that of the control mice ( Figure 5 ): 10% (1/10) of the control mice died within 72 h, whereas 66.7% (6/9) of the transgenic mice observed in the control mice ( Figure 3C ). The vehicle of died. With a dose of 10.0 mg/kg, there was a trend toward PAF had little or no effect in either group. increased sensitivity to the bacterial endotoxin: a mortality of 50% (5/10) for the transgenic mice and 20% (2/10) mortality for the control littermates. Simultaneous injection Increased bronchopulmonary response to methacholine of WEB 2086 (10 mg/kg) with endotoxin (15 mg/kg) afforded good protection of the transgenic mice from After nebulized methacholine was administered to mice through the trachea, the total lung resistance was calcuendotoxin-induced death (Table III) . lated. While high doses of methacholine elicited a substantial bronchoconstriction in the control mice, resultant Hyperplasias of various cutaneous cells and melanocytic tumor formation methacholine dose-response curves ( Figure 4A ) revealed a significant bronchial hyperreactivity in PAFR transgenic
The transgenic mice had remarkable black patches on the skin of the ear and the tail, irrespective of coat color mice. On the basis of the dose-response curves, we evaluated the EC 200 , the dose required to obtain a 100% ( Figure 6A ); this phenotype was more noticeable in females and was also present in the 55-L transgenic line. increase in the total lung resistance of the baseline. The EC 200 of the transgenic mice was significantly smaller Skin pigmentation was appreciable at~3-4 weeks old, and increased with age (data not shown). The areas with than that of the littermate control mice ( Figure 4B ), suggesting that the airways of transgenic animals were severe pigmentation were thicker than normal, though the degree of hyperpigmentation differed between individuals. more sensitive to methacholine than those of the controls. The hyperreactivity to methacholine was practically When ear sections of the control mice were stained with hematoxylin and eosin, pigment-containing cells were reversed by the prior i.v. administration of a PAF antagonist, WEB 2086 (Figure 4) . Even in the control mice, the observed occasionally in the dermis. The epidermis of the control mice consisted of one or two cell layers ( Figure  7A ). In contrast, the transgenic mice had a large number of pigment-containing cells in the dermis, where hyperplasia of fibroblasts was also observed. In the epidermis, taining cells in the dermis revealed that they were melanocytes, but not melanophages ( Figures 8A and C) . The acanthosis (hyperplasia of the epidermis) was evident ( Figure 7B ). Due to these hyperplasias, the pinna was dermal melanocytes of both the control and transgenic mice contained many melanosomes. The majority of them markedly thickened (compare Figure 7A and B). There were trends for nests of the pigment-containing cells to were in mature stage IV (Figures 8B and D) . However, in the transgenic mice, melanosomes in developmental be present beneath the acanthotic epidermis, and for severe pigmentation to occur at the lateral and the dorsal region stage II and III were frequently observed, indicating the active melanogenesis in PAFR transgenic mice. The of the pinna. To identify the nature of the pigment, these sections were subjected to Fontana-Masson staining, a melanocytes of transgenic mice were characterized further with enlarged perikarya with well-developed endoplasmic diagnostic staining for melanin. Since most colored cells were strongly stained (Figure 7C ), the pigmentation proved reticula, numerous mitochondria and hypertrophic Golgi complexes ( Figure 8D ). to be due to the increased number of melanin-containing cells. Both hyperthickening of the skin and melanosis in
In three out of 14 aged female transgenic mice (Ͼ15 months old), melanocytic tumors arose spontaneously in the dermis were also present in the tail (data not shown). In the dermis of the transgenic ear, the number of the ear ( Figure 6B ). One of them also developed a tumor in the tail (data not shown). Histopathological examination mast cells increased (data not shown), consistent with a persistent scratching behavior of the transgenic mice.
revealed that the tumors were located in the dermis (data not shown), suggesting that the tumors derived from Electron microscopic examination of the melanin-con-transgenic mice, using the same expression unit (Ikematsu et al., 1993; . A fraction of 55-H transgenic mice, despite the restricted pattern of transgene expression, may not survive gestation (Table II) . Thus, even a limited overexpression may still be lethal to some transgenic embryos. The reason for this partial penetrance remains elusive, although the presence of modifying genes that affect the level of the PAFR transgene expression is plausible, as suggested in studies on exencephaly of p53-deficient embryos (Sah et al., 1995) . The female transgenic embryos seem to be more difficult to develop than male transgenic embryos (Table I) , possibly because the transgene might be expressed more effectively in the female embryos. Alternatively, there might be a sex-dependent effect of PAFR signaling on the embryo. Fertility of the transgenic female is affected by the transgene to a greater extent than that of transgenic males. A higher expression of PAFR in the female reproductive system might easily cause the disorders in fertilization.
Enhanced sensitivity to PAF
We found abundant expression of PAFR protein in the heart of the transgenic mice. These mice had remarkable bradycardia and arrhythmia immediately after the adminis- in vivo, with successful coupling to murine intracellular effector systems.
Due to the airway constriction shown in Figure 3B , the the hyperplastic melanocytes. The tumor cells did not metastasize after several months. The control mice showed total lung resistance seemed to be elevated ( Figure 3A ). High level transgenic mRNA was seen in the trachea, but no such tendency to tumor formation.
In summary, multiple abnormalities were observed in the messenger was hardly detectable in the lung ( Figure  2B ). This may reflect the fact that the proportion of airway the transgenic mice overexpressing PAFR in various tissues, including breeding abnormality, hyperresponsivesmooth muscle cells is likely to be lower in the lung tissue than that in the trachea. Alternatively, intravenously ness to methacholine or bacterial endotoxin, and aberrant pigmentation and subsequent tumor formation.
administered PAF may stimulate production of other mediators which in turn cause bronchoconstriction.
Discussion

Bronchial hyperreactivity
Reversible bronchial hyperreactivity underlies the pathoHighly deviated expression of the transgene and abnormal breeding physiology of asthma, yet the precise mediators of the response are unclear. PAF administration to both experiUbiquitous expression of endogenous PAFR mRNA has been reported in all species investigated (Honda et al., mental animals (Mazzoni et al., 1985; Chung et al., 1986) and humans (Cuss et al., 1986 ) induces a bronchial 1991; Ye et al., 1991; Bito et al., 1994; Ishii et al., 1996) . In an attempt to overexpress PAFR mRNA ubiquitously hyperreactivity that resembles the pathology seen in asthmatics. Though a number of reports have referred to in transgenic mice, we used the chicken β-actin promoter and CMV enhancer (Niwa et al., 1991) , which is known the mechanisms of PAF-induced bronchial hyperreactivity, much remains to be elucidated (Chung and Barnes, 1991 ; to direct a widespread gene expression (Shimada et al., 1993; Honda et al., 1995) . However, the transgene expresPage, 1992). Since the transgenic mice showed a heightened airway responsiveness to PAF (Figure 3 ), sion was not ubiquitous ( Figure 2B ). The restricted expression pattern suggests that the ubiquitous overexpression response of the airway to methacholine, a spasmogen widely used to diagnose bronchial hyperreactivity, was of PAFR may be embryonically lethal to mice. In fact, PAF has been shown to be involved in ovulation, implantstudied. Airway contractile tissues in mice respond to intravenously administered methacholine (Martin et al., ation, fetal lung maturation and the initiation and maintenance of parturition (O'Neill, 1992; Pike et al., 1992; . Airways of the transgenic mice showed hyperreactivity Toyoshima et al., 1995) . Moreover, failure in the regulation of PAF metabolism has been suggested to elicit premature to methacholine aerosols (Figure 4) . Because a specific PAF antagonist, WEB 2086, blocked it, this phenomenon delivery and infertility (Narahara et al., 1995; Toyoshima et al., 1995) . Expression of the PAFR transgene in the relates directly to the interaction of PAF and PAFR. Additionally, even in the control mice, this PAF antagonist early embryonic stage can be deduced from studies of decreased the reactivity to methacholine (Figure 4) . In such as eicosanoids (Chao and Olson, 1993) . The direct activation of PAFR by endotoxin is another possibility, as both transgenic and control mice, endogenous PAF may be the physiological regulator of airway contraction by we previously demonstrated (Nakamura et al., 1992; Waga et al., 1993) . muscarinic stimulation. However, endogenous PAF does not seem to have any effects on resting tone of the airways, because no significant difference was observed in baseline Cutaneous proliferative disorders We detected a small number of melanocytes in the dermis values of the total lung resistance between the transgenic and control mice ( Figure 4A) .
of ear and tail of the normal mice ( Figure 7A ), indicating that the hyperplastic melanocytes were not ectopic. Since Eosinophil products have been postulated to contribute to bronchial hyperreactivity through damage to the airway we could not observe melanophages in the hyperpigmented area, the melanocytes seem to proliferate abnormally epithelium, leaving underlying smooth muscle more susceptible to non-specific contractile mediators (Gleich et al., without inflammation. The coat color of the transgenic mice was not altered substantially (for example, see Figure  1988 ). PAF-induced bronchial hyperreactivity has been reported to be associated with eosinophil infiltration into 6A). This is because the increase in melanocytes was restricted only to the dermis. Due to the lack of nerve the airway (Coyle et al., 1988) . PAFR transgenic mice, under resting conditions, showed no evidence of airway cell-like dendrites, it is unlikely that the hyperplastic melanocytes discharge melanosomes into surrounding cells eosinophil infiltration (unpublished data). Also, the onset and resolution of airway contractile responses to methacho-( Figure 8B) . Melanocytes with such a morphology were also observed in the dermis of the pigmented area of line were rapid. Thus, it seems unlikely that eosinophils could mediate the hyperreactivity seen in the transgenic nevus Ota, and were different from melanocytes in the hair follicles and the epidermis. mice. As Page (1992) suggested, PAF is probably capable of causing acute bronchial hyperreactivity, without
There are two kinds of animal models with melanosis in the dermis and subsequent tumor formation. In transinflammation. The uncoupling of airway eosinophilia and bronchial hyperreactivity has been demonstrated by other genic mice with the ret oncogene fused to the metallothionein-I promoter as a transgene (Iwamoto et al., 1991) , in vivo systems; pre-treatment of guinea-pig with a PAF antagonist abrogated the antigen-induced airway hypersevere systemic melanosis was present at birth. At the age of several months, the transgenics developed melanocytic reactivity to acetylcholine with no effect on the eosinophilia (Ishida et al., 1990) .
tumors that grew slowly and did not metastasize. On the other hand, malignant melanoma spontaneously arose in It remains to be clarified whether methacholine induces synthesis and release of PAF, to which the transgenic another transgenic mouse expressing the SV40 early region oncogenic sequences under the control of the tyrosinase airways respond remarkably, or whether the overexpression of PAFR increases the muscarinic receptor density promoter (Bradl et al., 1991; Klein-Szanto et al., 1991) . In PAFR transgenic mice, aberrant melanogenesis was and/or function. In any event, the PAFR overexpression per se seems to be sufficient to mimic the symptoms significant several weeks after birth and was accompanied by acanthosis. Furthermore, the melanocytic tumor did elicited by administration of PAF. Indeed, enhancement of myocardial function was evoked by overexpressing β 2 -not metastasize. Therefore, our animal model is distinguishable from the above transgenic lines, suggesting a adrenergic receptor in transgenic mice (Milano et al., 1994) . Our data may, at least in part, account for the different mechanism of tumor formation. PAFRs were identified on human keratinocytes (Travers airway hyperreactivity of asthmatics who show an increase in PAFR mRNA expression level in the lung (Shirasaki et al., 1995) , and production of PAF by human fibroblasts (Michel et al., 1988) and keratinocytes (Michel et al., 1989 (Michel et al., ) et al., 1994 . was demonstrated. Additionally, it has been suggested that PAF contributes to the development and maintenance of Endotoxin-induced death Severe Gram-negative bacterial infection can lead to cutaneous inflammation and the pathogenesis of inflammatory dermatoses . Howdevelopment of endotoxic shock, a state characterized by hypotension, multiorgan failure and, potentially, death ever, there are, as far as we know, no reports regarding PAF-related hyperplasias of melanocytes, keratinocytes (Bone, 1991) . This syndrome is secondary to the effects of endotoxin, the LPS-containing portion of the bacterial and fibroblasts, or tumor formation. Therefore, the proliferative effects of PAFR on the cutaneous cells are of cell wall. Because pharmacological studies have suggested that PAF is one of the potent mediators of endotoxic shock particular interest. PAF has been reported to up-regulate the proliferation of lymphocytes (Behrens and Goodwin, (Casals-Stenzel, 1987; Imanishi et al., 1991; Terashita et al., 1992) , we determined whether the transgenic mice 1990; Leprince et al., 1991) . We observed that PAFR stimulated mitogen-activated protein kinase (Honda et al. , would be more sensitive to bacterial endotoxin. This possibility was analyzed by monitoring the mortality of 1994) which plays a key role in transducing extracellular mitogenic signals. Additionally, it is reported that repeated mice after the i.v. injection of endotoxin. Our results indicate that overexpression of PAFR causes an increased administration of arachidonic acid to the skin of mouse ears results in epidermal hyperplasia (Bouclier et al., sensitivity to endotoxin ( Figure 5 and Table III) . Although molecular mechanisms underlying the hypersensitivity to 1989). This report is consistent with our findings because arachidonic acid is known to be released in response to endotoxin are unclear, endotoxin is known to increase the serum level of PAF (Doebber et al., 1985; Chang et al., PAF stimulation (Chao and Olson, 1993) . Some types of human cutaneous cells release various 1987), which may cause dysfunction of the target organs such as the heart. Alternatively, the released PAF may growth factors regulating development and proliferation of the other types of cutaneous cells. Keratinocytes produce produce lethal amounts of other vasoactive mediators was dissolved in sterile 1/2ϫ phosphate-buffered saline at a concentration growth factors for melanocytes, such as basic fibroblast of 5 μg/ml. growth factor (Halaban et al., 1988) and endothelin-1 (Imokawa et al., 1995) . Fibroblasts and keratinocytes are Creation and identification of transgenic mice reported to release stem cell factor, the ligand for the Methods utilized in the creation of transgenic mice have been described previously (Hogan et al., 1986) . The purified DNA fragment was injected product of the c-kit proto-oncogene (Grabbe et al., 1994) .
into the pronuclei of fertilized eggs (BDF 2 ) from superovulated BDF 1 This factor can stimulate mast cell development, proliferfemales (Charles River Japan Inc., Yokohama, Japan) mated with BDF 1 ation and mediator release, as well as melanocyte prolifermales. Offspring were weaned at 4 weeks old. For genotyping, genomic ation and melanin production (Grabbe et al., 1994) . In DNAs were isolated from tail biopsies, and were subjected to 30 cycles of PCR amplification (1 min at 94°C; 2 min at 55°C; 2 min at 72°C). Genomic DNAs (1.2 μg) of transgenic mice were digested with ApaI to release the transgene, electrophoresed in a 0.7% agarose gel, and transferred to a Hybond-Nϩ membrane using 0.4 M NaOH according
Conclusions
to Chomczynski (1992) . As a probe, a 933 bp SmaI-SmaI fragment of PAFR overexpression in the transgenic mice led to a the guinea-pig PAFR cDNA (Honda et al., 1991) was labeled with hypersensitivity, not only to PAF but also to other ligands [α-32 P] dCTP by a Megaprime DNA labeling system (Amersham Corp., such as methacholine or bacterial endotoxin. Thus, these Tokyo). Hybridization and wash were performed under the same conditions described previously (Ishii et al., 1996) . Hybridization intensities transgenic mice are a useful model for studying the were compared with standards composed of control mouse genomic basic pathophysiology of bronchial asthma and endotoxin-DNA containing variable amounts of the transgene.
induced death, and screening of therapeutics for these disorders. The overexpression of PAFR led to pathologies Northern blot analysis Total RNAs were isolated from transgenic and control mouse tissues as in the skin and in the reproductive system. These findings described previously (Ishii et al., 1996) . Quantitative and qualitative provide new and important insights regarding morphoassessments of the total RNAs were determined spectrophotometrically genesis of dermal-epidermal tissues by cell-cell interand electrophoretically on 1% agarose gels, respectively. To determine action, and the underlying mechanisms of gender bias and tissue expression, total RNAs were separated by electrophoresis and infertility.
transferred to a Hybond-Nϩ membrane as described previously (Ishii et al., 1996) . The membrane was hybridized with the guinea-pig cDNA probe and washed under the conditions described previously (Ishii et al., 1996) . The same membrane was dehybridized sequentially and hybridized
Materials and methods
with the Eco47III-SpeI fragment of a murine PAFR gene DNA probe Reagents (Ishii et al., 1996) or a human glyceraldehyde-3-phosphate dehydrogenase Materials and chemicals were obtained from the following sources.
(GAPDH) cDNA probe (Human G3PDH cDNA Probe, Clontech, Palo [α-32 P]dCTP (111 TBq/mmol) and transfer membrane (Hybond-Nϩ) Alto, CA). were from Amersham Corp., Tokyo, Japan; [ 3 H]WEB 2086 (521.7 GBq/ mmol), from Du Pont/NEN, Tokyo; restriction enzymes and DNARadioligand binding assay modifying enzymes, from Takara, Kyoto, Japan; agaroses (Sea Kem, Nu
Crude myocardial membranes were prepared by homogenizing a whole Sieve and Sea Plaque), from FMC, Rockland, ME; PAF (1-O-hexadecylheart in ice-cold buffer [25 mM Tris-HCl (pH 7.4), 5 mM EDTA, 2-acetyl-sn-glycero-3-phosphocholine), from Cayman Chemical, Ann 0.25 M sucrose, 100 μM leupeptin, and 40 kIU/ml aprotinin]. Nuclei Arbor, MI; bovine serum albumin (BSA), methacholine (acetyl-β-were sedimented at 800 g for 20 min. Membranes were sedimented at methylcholine chloride) and endotoxin (LPS, E.coli serotype O127:B8, 100 000 g for 60 min and washed once in the binding buffer , from Sigma Chemical Co., St Louis, MO; and HEPES-NaOH (pH 7.4), 10 mM MgCl 2 , and 0.25 M sucrose] before pyrogen-free saline, from Otsuka Pharmaceuticals, Tokyo, Japan. Unresuspension in 500 μl of the buffer. Ligand binding assays were labeled WEB 2086 was a generous gift from Boehringer Ingelheim, performed in duplicate using 100 μl of the membrane suspensions (1.56-Ingelheim, Germany. Other materials and reagents were of analytical 2.83 mg protein/ml). The concentration of the PAFR ligand, [ 3 H]WEB grade. PAF was dissolved in saline containing 0.25% BSA just before 2086, was 50 nM, and the non-specific binding was determined in the use. Methacholine was dissolved in saline. WEB 2086 was dissolved in presence of 20 μM unlabeled WEB 2086. Assays were done at 25°C saline by sonication at a concentration of 0.5 mg/ml. Endotoxin was for 60 min, then the mixtures were passed through GF/C glass filters suspended in saline.
(Whatman International Ltd., Maidstone, UK), which were then washed and counted in a liquid scintillator (Scintisol; Dojindo Laboratories, Kumamoto, Japan). Specific binding was normalized to membrane Plasmid construction The transgene was constructed as follows. A 1653 bp NcoI-NcoI protein. Protein concentration was determined by the method of Bradford (1976) with BSA as a standard. fragment containing the coding region of guinea-pig PAFR was excised from Zp74 (Honda et al., 1991) . Cohesive ends were blunted with Klenow fragment and ligated to EcoRI linkers. The resulting fragment Total lung resistance The transgenic mice and their littermate controls (male, 13-24 weeks was introduced into the EcoRI site of pCXN2, a derivative of pCAGGS (Niwa et al., 1991) . The final construct consists of the CMV immediate old) were anesthetized with a mixture of ketamine and pentobarbital (25 mg/kg each) by intraperitoneal injection. A metal cannula (inner early enhancer, 5Ј-flanking sequence, exon 1 containing 5Ј-untranslated sequence and the first intron of the chicken β-actin gene, the rabbit diameter ϭ 1.0 mm) was inserted in the trachea of a tracheostomized mouse. The animal was ventilated mechanically (Model 683; Harvard β-globin splice acceptor site followed by the guinea-pig PAFR sequence, and the rabbit β-globin polyadenylation site. To remove vector sequences Apparatus, South Natick, MA) at a frequency of 150 breaths/min with a tidal volume of 8 ml/kg and a positive end-expiratory pressure of prior to microinjection, cesium chloride-purified plasmid was digested with BamHI, and the 4.1 kb BamHI-BamHI fragment was separated by 3 cmH 2 O. The thorax was opened wide by means of a midline sternotomy and wide lateral incisions along the costal diaphragmatic margins. A agarose gel electrophoresis, extracted from the gel using GELase (Epicentre Technologies, Madison, WI) and purified with QIAGEN-tip paralytic agent (pancuronium bromide, 0.1 mg/kg) was administered intraperitoneally to eliminate spontaneous respirations. During the experi-(Qiagen Inc., Chatsworth, CA). The purified BamHI-BamHI fragment
